Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 7
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Kayser S, Martínez-Cuadrón D, Hanoun M, Stölzel F, Gil C, Reinhardt HC, Aguiar E, Schäfer-Eckart K, Burgues JMB, Steffen B, Bernal T, Krause SW, Riaza R, Schliemann C, Cervera J, Kaufmann M, Torres-Miñana L, Hänel M, Acuña-Cruz E, Jost E, Algarra JL, Crysandt M, Fransecky L, Cornago-Navascues J, Kraus S, Martinez-Lopez J, Einsele H, Niemann D, Neubauer A, Seggewiß-Bernhardt R, Scholl S, Klein SA, Schmid C, Schaich M, Schmidt-Hieber M, Zukunft S, Ho AD, Platzbecker U, Baldus CD, Müller-Tidow C, Thiede C, Bornhäuser M, Serve H, Levis M, Montesinos P, Röllig C, Schlenk RF. Kayser S, et al. Among authors: acuna cruz e. Haematologica. 2023 Jan 1;108(1):34-41. doi: 10.3324/haematol.2022.281137. Haematologica. 2023. PMID: 35678031 Free PMC article.
Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain.
Ribera JM, García O, Buendía-Ureña B, Terol MJ, Vicent A, Vall-Llovera F, Bergua J, García-Cadenas I, Esteve J, Ribera J, Acuña-Cruz E, Herrera P, Hernández-Rivas JM, Abrisqueta P, González-Campos J, Rodríguez C, Bastos-Oreiro M, Genescà E, Caminos N, Queipo de Llano MP, Cladera A, Sancho JM; Members of PETHEMA: Josep-Maria Riberaa, Olga Garcíaa, Ferran Vall-Lloverae, Juan Berguaf, Irene García-Cadenasg, Jordi Esteveh, Jordi Riberaa, Evelyn Acuña-Cruzi, Jesus-Maria Hernández-Rivas, José González-Camposm, Eulàlia Genescàa, Maria-Paz Queipo de Llanoq, Antònia Claderar Members of GELTAMO: Buenaventura Buendía-Ureñab, Maria-José Terolc, Ana Vicentd, Pilar Herreraj, Pau Abrisquetal, Carlos Rodríguezn, Mariana Bastos-Oreiroo, Nerea Caminosp, Juan-Manuel Sanchoa Groups. Ribera JM, et al. Among authors: acuna cruz e. Leuk Lymphoma. 2022 Aug;63(8):1993-1996. doi: 10.1080/10428194.2022.2053531. Epub 2022 Mar 27. Leuk Lymphoma. 2022. PMID: 35343365 No abstract available.
Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients.
Boluda B, Martínez-Cuadrón D, Algarra L, Cano I, Sayas MJ, Acuña-Cruz E, Blanco A, Marco-Ayala J, DeLapuerta R, Díaz-González Á, Tormo M, Rodríguez-Veiga R, García R, Piñana JL, López-Pavía M, Barragán E, Amigo ML, Sargas C, López A, Solana-Altabella A, Gil C, Megías-Vericat JE, Sanz MA, Montesinos P. Boluda B, et al. Among authors: acuna cruz e. Leuk Lymphoma. 2021 Nov;62(11):2727-2736. doi: 10.1080/10428194.2021.1938031. Epub 2021 Jun 14. Leuk Lymphoma. 2021. PMID: 34121593
Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
Megías-Vericat JE, Martínez-Cuadrón D, Herrero MJ, Rodríguez-Veiga R, Solana-Altabella A, Boluda B, Ballesta-López O, Cano I, Acuña-Cruz E, Cervera J, Poveda JL, Sanz MÁ, Aliño SF, Montesinos P. Megías-Vericat JE, et al. Among authors: acuna cruz e. Pharmacogenet Genomics. 2021 Aug 1;31(6):133-139. doi: 10.1097/FPC.0000000000000431. Pharmacogenet Genomics. 2021. PMID: 33675324
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia.
Boluda B, Solana-Altabella A, Cano I, Martínez-Cuadrón D, Acuña-Cruz E, Torres-Miñana L, Rodríguez-Veiga R, Navarro-Vicente I, Martínez-Campuzano D, García-Ruiz R, Lloret P, Asensi P, Osa-Sáez A, Aguero J, Rodríguez-Serrano M, Buendía-Fuentes F, Megías-Vericat JE, Martín-Herreros B, Barragán E, Sargas C, Salas M, Wooddell M, Dharmani C, Sanz MA, De la Rubia J, Montesinos P. Boluda B, et al. Among authors: acuna cruz e. Cancers (Basel). 2023 Apr 12;15(8):2267. doi: 10.3390/cancers15082267. Cancers (Basel). 2023. PMID: 37190195 Free PMC article.
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
Megías-Vericat JE, Martínez-Cuadrón D, Herrero MJ, Rodríguez-Veiga R, Solana-Altabella A, Boluda B, Ballesta-López O, Cano I, Acuña-Cruz E, Cervera J, Poveda JL, Sanz M, Aliño SF, Montesinos P. Megías-Vericat JE, et al. Among authors: acuna cruz e. Leuk Lymphoma. 2021 Mar;62(3):659-668. doi: 10.1080/10428194.2020.1839650. Epub 2020 Nov 2. Leuk Lymphoma. 2021. PMID: 33135528
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study.
Solana-Altabella A, Megías-Vericat JE, Ballesta-López O, Boluda B, Cano I, Acuña-Cruz E, Rodríguez-Veiga R, Torres-Miñana L, Sargas C, Sanz MÁ, Borrell-García C, López-Briz E, Poveda-Andrés JL, De la Rubia J, Montesinos P, Martínez-Cuadrón D. Solana-Altabella A, et al. Among authors: acuna cruz e. Cancers (Basel). 2022 Apr 11;14(8):1921. doi: 10.3390/cancers14081921. Cancers (Basel). 2022. PMID: 35454828 Free PMC article.
Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy.
Shallis RM, Stahl M, Wei W, Montesinos P, Lengline E, Neukirchen J, Bhatt VR, Sekeres MA, Fathi AT, Konig H, Luger S, Khan I, Roboz GJ, Cluzeau T, Martínez-Cuadron D, Raffoux E, Germing U, Umakanthan JM, Mukhereje S, Brunner AM, Miller A, McMahon CM, Ritchie EK, Rodríguez-Veiga R, Itzykson R, Boluda B, Rabian F, Tormo M, Acuña-Cruz E, Rabinovich E, Yoo B, Cano I, Podoltsev NA, Bewersdorf JP, Gore S, Zeidan AM. Shallis RM, et al. Among authors: acuna cruz e. Leuk Lymphoma. 2020 May;61(5):1220-1225. doi: 10.1080/10428194.2020.1728753. Epub 2020 Feb 26. Leuk Lymphoma. 2020. PMID: 32100599 Free PMC article. No abstract available.
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients.
Martínez Sánchez MP, Megías-Vericat JE, Rodríguez-Veiga R, Vives S, Bergua JM, Torrent A, Suárez-Varela S, Boluda B, Martínez-López J, Cano-Ferri I, Acuña-Cruz E, Torres-Miñana L, Martín-Herreros B, Serrano A, Sempere A, Barragán E, Sargas C, Sanz M, Martínez-Cuadrón D, Montesinos P; PETHEMA group. Martínez Sánchez MP, et al. Among authors: acuna cruz e. Ann Hematol. 2021 Jun;100(6):1497-1508. doi: 10.1007/s00277-021-04542-8. Epub 2021 Apr 29. Ann Hematol. 2021. PMID: 33914097 Clinical Trial.
Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain.
Boluda B, Solana-Altabella A, Cano I, Acuña-Cruz E, Rodríguez-Veiga R, Ballesta-López O, Megías-Vericat JE, Martínez-Cuadrón D, Gómez I, Solves P, Lorenzo I, Piñana JL, Sanz J, Guerreiro M, Montoro Gómez J, Díaz-González A, Marco J, Blanco A, Sanz MÁ, Montesinos P. Boluda B, et al. Among authors: acuna cruz e. J Clin Apher. 2021 Aug;36(4):612-620. doi: 10.1002/jca.21901. Epub 2021 May 8. J Clin Apher. 2021. PMID: 33964038 Free PMC article.
13 results